BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20669327)

  • 1. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
    Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset autosomal-recessive parkinsonian-pyramidal syndrome.
    Lai HJ; Lin CH; Wu RM
    Acta Neurol Taiwan; 2012 Sep; 21(3):99-107. PubMed ID: 23196729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
    Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
    Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
    Radi E; Formichi P; Di Maio G; Battisti C; Federico A
    J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.
    Di Fonzo A; Dekker MC; Montagna P; Baruzzi A; Yonova EH; Correia Guedes L; Szczerbinska A; Zhao T; Dubbel-Hulsman LO; Wouters CH; de Graaff E; Oyen WJ; Simons EJ; Breedveld GJ; Oostra BA; Horstink MW; Bonifati V
    Neurology; 2009 Jan; 72(3):240-5. PubMed ID: 19038853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare causes of dystonia parkinsonism.
    Schneider SA; Bhatia KP
    Curr Neurol Neurosci Rep; 2010 Nov; 10(6):431-9. PubMed ID: 20694531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
    Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
    Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease.
    Shen T; Pu J; Lai HY; Xu L; Si X; Yan Y; Jiang Y; Zhang B
    Sci Rep; 2018 Sep; 8(1):14028. PubMed ID: 30232368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
    Chu YT; Lin HY; Chen PL; Lin CH
    BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism.
    Magrinelli F; Mehta S; Di Lazzaro G; Latorre A; Edwards MJ; Balint B; Basu P; Kobylecki C; Groppa S; Hegde A; Mulroy E; Estevez-Fraga C; Arora A; Kumar H; Schneider SA; Lewis PA; Jaunmuktane Z; Revesz T; Gandhi S; Wood NW; Hardy JA; Tinazzi M; Lal V; Houlden H; Bhatia KP
    Mov Disord; 2022 Jan; 37(1):148-161. PubMed ID: 34622992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
    Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
    Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa-Responsive Parkinsonism Due to
    Chien HF; Rodriguez RD; Bonifati V; Nitrini R; Pasqualucci CA; Gelpi E; Barbosa ER
    Neurology; 2021 Oct; 97(16):763-766. PubMed ID: 34475127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
    Behrens MI; Brüggemann N; Chana P; Venegas P; Kägi M; Parrao T; Orellana P; Garrido C; Rojas CV; Hauke J; Hahnen E; González R; Seleme N; Fernández V; Schmidt A; Binkofski F; Kömpf D; Kubisch C; Hagenah J; Klein C; Ramirez A
    Mov Disord; 2010 Sep; 25(12):1929-37. PubMed ID: 20683840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families.
    Bohlega SA; Al-Mubarak BR; Alyemni EA; Abouelhoda M; Monies D; Mustafa AE; Khalil DS; Al Haibi S; Abou Al-Shaar H; Faquih T; El-Kalioby M; Tahir AI; Al Tassan NA
    BMC Res Notes; 2016 Jun; 9():295. PubMed ID: 27268037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal recessive parkinsonism.
    Bonifati V
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S4-6. PubMed ID: 22166450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of PLA2G6 as a locus for dystonia-parkinsonism.
    Paisan-Ruiz C; Bhatia KP; Li A; Hernandez D; Davis M; Wood NW; Hardy J; Houlden H; Singleton A; Schneider SA
    Ann Neurol; 2009 Jan; 65(1):19-23. PubMed ID: 18570303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.
    Williams DR; Hadeed A; al-Din AS; Wreikat AL; Lees AJ
    Mov Disord; 2005 Oct; 20(10):1264-71. PubMed ID: 15986421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
    Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
    Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.